CNS Pharmaceuticals (NASDAQ:CNSP) initiated with Speculative Buy rating at Benchmark.
Proteostasis Therapeutics (NASDAQ:PTI) resumed with Overweight rating and $8 (203% upside) price target at Cantor Fitzgerald. Shares up 3% premarket.
SpringWorks Therapeutics (NASDAQ:SWTX) initiated with Buy rating and $33 (27% upside) price target at H.C. Wainwright.
STAAR Surgical Company (NASDAQ:STAA) initiated with Buy rating and $46 (25% upside) price target at BTIG Research.
Cidara Therapeutics (NASDAQ:CDTX) upgraded to Buy at WBB Securities.
Zimmer Biomet Holdings (NYSE:ZBH) upgraded to Strong Buy with a $170 (19% upside) price target at Raymond James. Shares up 1% premarket.
ViewRay (NASDAQ:VRAY) downgraded to Neutral with a $199 price target at Compass Point. Shares down 6% premarket in response to its equity offering.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.